Journal profile · Multiple
Rheumatology and Immunology Research
ISSN 2719-4523 · Walter de Gruyter
Rheumatology and Immunology Research: CAS Zone 3 · Medicine (2026 Xinrui edition); fully open access; APC charged, amount not published; median 100 days to acceptance (58 articles, last 24 months); 32 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Rheumatology and Immunology Research is published by Walter de Gruyter and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Systemic Sclerosis and Related Diseases, together about 37.8% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Systemic Lupus Erythematosus ResearchMedicine15.3%
- Rheumatoid Arthritis Research and TherapiesMedicine14.4%
- Systemic Sclerosis and Related DiseasesMedicine8.1%
- Vasculitis and related conditionsMedicine6.6%
- Spondyloarthritis Studies and TreatmentsMedicine5.4%
- Autoimmune and Inflammatory Disorders ResearchMedicine4.8%
- Inflammatory Myopathies and DermatomyositisMedicine4.8%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.86LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 44OpenAlex ·
- 2-year mean citedness
- 2.59OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 27LetPub ·
Articles by year OpenAlex count · 200 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 1 |
| 2025 | 32 | 32 | 50 |
| 2024 | 33 | 33 | 172 |
| 2023 | 33 | 33 | 252 |
| 2022 | 37 | 37 | 343 |
| 2021 | 35 | 35 | 359 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
100 daysMedian, submission to acceptance · P25–P75 64 days – 126 days
- Acceptance to online
- median 80 days (58 articles)
- Submission to online
- median 181 days
- Sample
- 58 articles with submission and acceptance dates (68 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 0 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Walter de Gruyter
- ISSN
- 2719-4523
FAQ
Frequently asked questions about Rheumatology and Immunology Research
What CAS zone is Rheumatology and Immunology Research in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Rheumatology and Immunology Research?
Based on the dates recorded on 58 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 64–126 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Rheumatology and Immunology Research?
According to LetPub and DOAJ records, Rheumatology and Immunology Research is indexed in ESCI and Scopus.
Is Rheumatology and Immunology Research open access, and what is the APC?
Rheumatology and Immunology Research is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .